Skip to main content
SpringerLink
Log in

Sarcoidosis

  • Reference work entry
  • First Online:
Compendium of Inflammatory Diseases

  • 28 Accesses

Synonyms

Boecks sarcoidosis; Heerfordt’s syndrome; Lofgren’s syndrome; Lupus pernio

Definition

Sarcoidosis is a multisystemic inflammatory disease characterized by the presence of noncaseating granulomas. In order to make the diagnosis, all other causes of granulomas must be excluded and the patient must have the appropriate clinical presentation.

Epidemiology and Genetics

Sarcoidosis is a worldwide disease. However, the incidence of the disease varies, with some ethnic groups such as Nordic and African Americans have an increased rate of disease (Hall et al. 1969). In Japan, the disease is more frequent in northern climates and in Europe, Scandinavian countries have significantly more disease than more southern areas, such as Italy and Greece. In the USA, however, the southeastern area has a higher frequency than that reported in the northwest or the Rocky Mountain States.

In addition to geographic variation, there is a variation of the manifestations of the disease based on genetic...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 899.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,099.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bakkers, M., Merkies, I. S., Lauria, G., Devigili, G., Penza, P., Lombardi, R., et al. (2009). Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology, 73(14), 1142–1148.

    Article  CAS  PubMed  Google Scholar 

  • Baltzan, M., Mehta, S., Kirkham, T. H., & Cosio, M. G. (1999). Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. American Journal of Respiratory and Critical Care Medicine, 160(1), 192–197.

    Article  CAS  PubMed  Google Scholar 

  • Barnabe, C., McMeekin, J., Howarth, A., & Martin, L. (2008). Successful treatment of cardiac sarcoidosis with infliximab. Journal of Rheumatology, 35(8), 1686–1687.

    PubMed  Google Scholar 

  • Baughman, R. P., & Lower, E. E. (2001). Infliximab for refractory sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 18, 70–74.

    CAS  PubMed  Google Scholar 

  • Baughman, R. P., & Lower, E. E. (2007). Evidence-based therapy for cutaneous sarcoidosis. Clinics in Dermatology, 25(3), 334–340.

    Article  PubMed  Google Scholar 

  • Baughman, R. P., & Nunes, H. (2012). Therapy for sarcoidosis: Evidence-based recommendations. Expert Review of Clinical Immunology, 8(1), 95–103.

    Article  PubMed  Google Scholar 

  • Baughman, R. P., Winget, D. B., Bowen, E. H., & Lower, E. E. (1997). Predicting respiratory failure in sarcoidosis patients. Sarcoidosis, 14, 154–158.

    CAS  Google Scholar 

  • Baughman, R. P., Weber, F. L., Bejarano, P. B., Koehler, A., & Lower, E. E. (1999). Methotrexate for chronic sarcoidosis: Hepatotoxicity assessed by liver biopsy. American Journal of Respiratory and Critical Care Medicine, 159, A342.

    Article  Google Scholar 

  • Baughman, R. P., Winget, D. B., & Lower, E. E. (2000). Methotrexate is steroid sparing in acute sarcoidosis: Results of a double blind, randomized trial. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 17, 60–66.

    CAS  PubMed  Google Scholar 

  • Baughman, R. P., Teirstein, A. S., Judson, M. A., Rossman, M. D., Yeager, H. J., Bresnitz, E. A., et al. (2001). Clinical characteristics of patients in a case control study of sarcoidosis. American Journal of Respiratory and Critical Care Medicine, 164, 1885–1889.

    Article  CAS  PubMed  Google Scholar 

  • Baughman, R. P., Lower, E. E., Ingledue, R., Kaufman, A. H. (2002a). Management of ocular sarcoidosis. Sarcoidosis Vasculitis Diffuse Lung Diseases, 23, 543–548.

    Google Scholar 

  • Baughman, R. P., Iannuzzi, M. C., Lower, E. E., Moller, D. R., Balkissoon, R., Winget, D. B., et al. (2002b). Use of fluticasone for acute symptomatic pulmonary sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 19, 198–204.

    PubMed  Google Scholar 

  • Baughman, R. P., Drent, M., Kavuru, M., Judson, M. A., Costabel, U., Du, B. R., et al. (2006a). Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. American Journal of Respiratory and Critical Care Medicine, 174(7), 795–802.

    Article  CAS  PubMed  Google Scholar 

  • Baughman, R. P., Judson, M. A., Teirstein, A., Yeager, H., Rossman, M., Knatterud, G. L., et al. (2006b). Presenting characteristics as predictors of duration of treatment in sarcoidosis. QJM, 99(5), 307–315.

    Article  CAS  PubMed  Google Scholar 

  • Baughman, R. P., Judson, M. A., Teirstein, A. S., Yeager, H., Rossman, M., Knatterud, G. L., et al. (2006c). Presenting characteristics as predictors of duration of treatment for sarcoidosis. Chest, 99, 307–315.

    Google Scholar 

  • Baughman, R. P., Sparkman, B. K., & Lower, E. E. (2007). Six-minute walk test and health status assessment in sarcoidosis. Chest, 132(1), 207–213.

    Article  PubMed  Google Scholar 

  • Baughman, R. P., Judson, M. A., Teirstein, A., Lower, E. E., Lo, K., Schlenker-Herceg, R., et al. (2008). Chronic facial sarcoidosis including lupus pernio: Clinical description and proposed scoring systems. American Journal of Clinical Dermatology, 9(3), 155–161.

    Article  PubMed  Google Scholar 

  • Baughman, R. P., Lower, E. E., & Kaufman, A. H. (2010a). Ocular sarcoidosis. Seminars in Respiratory and Critical Care Medicine, 31(4), 452–462.

    Article  PubMed  Google Scholar 

  • Baughman, R. P., Engel, P. J., Taylor, L., & Lower, E. E. (2010b). Survival in sarcoidosis associated pulmonary hypertension: The importance of hemodynamic evaluation. Chest, 138, 1078–1085.

    Article  PubMed  Google Scholar 

  • Baughman, R. P., Lower, E. E., & Gibson, K. (2012a). Pulmonary manifestations of sarcoidosis. Presse Médicale, 41, e289–e302.

    Article  Google Scholar 

  • Baughman, R. P., Weiss, K. L., & Golnik, K. C. (2012b). Neuro-ophthalmic sarcoidosis. Eye and Brain, 4, 13–25.

    Article  CAS  Google Scholar 

  • Baughman, R. P., Meyer, K. C., Nathanson, I., Angel, L., Bhorade, S. M., Chan, K. M., et al. (2012c). Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American college of chest physicians evidence-based clinical practice guidelines. Chest, 142(5), e1S–e111S.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bhat, P., Cervantes-Castaneda, R. A., Doctor, P. P., Anzaar, F., & Foster, C. S. (2009). Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocular Immunology and Inflammation, 17(3), 185–190.

    Article  CAS  PubMed  Google Scholar 

  • Bradley, D. A., Lower, E. E., & Baughman, R. P. (2006). Diagnosis and management of spinal cord sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 23(1), 58–65.

    PubMed  Google Scholar 

  • Braswell, R. A., & Kline, L. B. (2007). Neuro-ophthalmologic manifestations of sarcoidosis. International Ophthalmology Clinics, 47(4), 67–77, ix.

    Article  PubMed  Google Scholar 

  • Browne, P. M., Sharma, O. P., & Salkin, D. (1978). Bone marrow sarcoidosis. JAMA, 240, 43–50.

    Article  Google Scholar 

  • Chambellan, A., Turbie, P., Nunes, H., Brauner, M., Battesti, J. P., & Valeyre, D. (2005). Endoluminal stenosis of proximal bronchi in sarcoidosis: Bronchoscopy, function, and evolution. Chest, 127(2), 472–481.

    Article  PubMed  Google Scholar 

  • Chapelon-Abric, C., de Zuttere, D., Duhaut, P., Veyssier, P., Wechsler, B., Huong, D. L., et al. (2004). Cardiac sarcoidosis: A retrospective study of 41 cases. Medicine (Baltimore), 83(6), 315–334.

    Article  Google Scholar 

  • Chung, E. S., Packer, M., Lo, K. H., Fasanmade, A. A., & Willerson, J. T. (2003). Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: Results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation, 107(25), 3133–3140.

    Article  CAS  PubMed  Google Scholar 

  • Cohen-Aubart, F., Galanaud, D., Grabli, D., Haroche, J., Amoura, Z., Chapelon-Abric, C., et al. (2010). Spinal cord sarcoidosis: Clinical and laboratory profile and outcome of 31 patients in a case–control study. Medicine (Baltimore), 89(2), 133–140.

    Article  Google Scholar 

  • Cremers, J., Drent, M., Driessen, A., Nieman, F., Wijnen, P., Baughman, R., et al. Liver-test abnormalities in sarcoidosis. European Journal of Gastroenterology & Hepatology. 2011.

    Google Scholar 

  • Dev, S., McCallum, R. M., & Jaffe, G. J. (1999). Methotrexate for sarcoid-associated panuveitis. Ophthalmology, 106, 111–118.

    Article  CAS  PubMed  Google Scholar 

  • Dumas, J. L., Valeyre, D., Chapelon-Abric, C., Belin, C., Piette, J. C., Tandjaoui-Lambiotte, H., et al. (2000). Central nervous system sarcoidosis: Follow-up at MR imaging during steroid therapy. Radiology, 214(2), 411–420.

    Article  CAS  PubMed  Google Scholar 

  • Erckens, R. J., Mostard, R. L., Wijnen, P. A., Schouten, J. S., & Drent, M. (2012). Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis. Graefes Archive for Clinical and Experimental Ophthalmology, 250, 713–720.

    Article  CAS  Google Scholar 

  • Galor, A., Jabs, D. A., Leder, H. A., Kedhar, S. R., Dunn, J. P., Peters, G. B., III, et al. (2008). Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology, 115(10), 1826–1832.

    Article  PubMed  Google Scholar 

  • Gerke, A. K., Yang, M., Tang, F., Cavanaugh, J. E., & Polgreen, P. M. (2012). Increased hospitalizations among sarcoidosis patients from 1998 to 2008: A population-based cohort study. BMC Pulmonary Medicine, 12, 19. doi:10.1186/1471-2466-12-19.:19-12.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gibson, G. J., Prescott, R. J., Muers, M. F., Middleton, W. G., Mitchell, D. N., Connolly, C. K., et al. (1996). British Thoracic Society Sarcoidosis study: Effects of long term corticosteroid treatment. Thorax, 51(3), 238–247.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gottlieb, J. E., Israel, H. L., Steiner, R. M., Triolo, J., & Patrick, H. (1997). Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest, 111(3), 623–631.

    Article  CAS  PubMed  Google Scholar 

  • Grunewald, J., & Eklund, A. (2007). Sex-specific manifestations of Lofgren’s syndrome. American Journal of Respiratory and Critical Care Medicine, 175(1), 40–44.

    Article  CAS  PubMed  Google Scholar 

  • Grunewald, J., & Eklund, A. (2009). Lofgren’s syndrome: Human leukocyte antigen strongly influences the disease course. American Journal of Respiratory and Critical Care Medicine, 179(4), 307–312.

    Article  PubMed  Google Scholar 

  • Hall, G., Naish, P., Sharma, O. P., Doe, W., & James, D. G. (1969). The epidemiology of sarcoidosis. Postgraduate Medical Journal, 45, 241–250.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hoitsma, E., Marziniak, M., Faber, C. G., Reulen, J. P., Sommer, C., De Baets, M., et al. (2002). Small fibre neuropathy in sarcoidosis. Lancet, 359(9323), 2085–2086.

    Article  CAS  PubMed  Google Scholar 

  • Hoitsma, E., De, V. J., & Drent, M. (2011). The small fiber neuropathy screening list: Construction and cross-validation in sarcoidosis. Respiratory Medicine, 105(1), 95–100.

    Article  PubMed  Google Scholar 

  • Hunninghake, G. W., & Crystal, R. G. (1981). Pulmonary sarcoidosis: A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. The New England Journal of Medicine, 305, 429–432.

    Article  CAS  PubMed  Google Scholar 

  • Hunninghake, G. W., Gilbert, S., Pueringer, R., Dayton, C., Floerchinger, C., Helmers, R., et al. (1994). Outcome of the treatment for sarcoidosis. American Journal of Respiratory and Critical Care Medicine, 149(4 Pt 1), 893–898.

    Article  CAS  PubMed  Google Scholar 

  • Jabs, D. A., & Johns, C. A. (1986). Ocular involvement in chronic sarcoidosis. American Journal of Ophthalmology, 102, 297–301.

    Article  CAS  PubMed  Google Scholar 

  • Jones, E., & Callen, J. P. (1990). Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. Journal of the American Academy of Dermatology, 23(3 Pt 1), 487–489.

    Article  CAS  PubMed  Google Scholar 

  • Judson, M. A. (2002). Hepatc, splenic, and gastrointestinal involvement with sarcoidosis. Seminars in Respiratory and Critical Care Medicine, 23, 529–543.

    Article  PubMed  Google Scholar 

  • Kahi, C. J., Saxena, R., Temkit, M., Canlas, K., Roberts, S., Knox, K., et al. (2006). Hepatobiliary disease in sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 23(2), 117–123.

    PubMed  Google Scholar 

  • Kavathia, D., Buckley, J. D., Rao, D., Rybicki, B., & Burke, R. (2010). Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis. Respiratory Medicine, 104(4), 564–570.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kennedy, P. T., Zakaria, N., Modawi, S. B., Papadopoulou, A. M., Murray-Lyon, I., du Bois, R. M., et al. (2006). Natural history of hepatic sarcoidosis and its response to treatment. European Journal of Gastroenterology and Hepatology, 18(7), 721–726.

    Article  CAS  PubMed  Google Scholar 

  • Kron, J., Sauer, W., Schuller, J., Bogun, F., Crawford, T., Sarsam, S., et al. (2013). Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace, 15, 347–354.

    Google Scholar 

  • Lower, E. E., & Weiss, K. L. (2008). Neurosarcoidosis. Clinics in Chest Medicine, 29(3), 475–492.

    Article  PubMed  Google Scholar 

  • Lower, E. E., Smith, J. T., Martelo, O. J., & Baughman, R. P. (1988). The anemia of sarcoidosis. Sarcoidosis, 5, 51–55.

    CAS  PubMed  Google Scholar 

  • Lower, E. E., Broderick, J. P., Brott, T. G., & Baughman, R. P. (1997). Diagnosis and management of neurologic sarcoidosis. Archives of Internal Medicine, 157, 1864–1868.

    Article  CAS  PubMed  Google Scholar 

  • Lower, E. E., Baughman, R. P., & Kaufman, A. H. (2012). Rituximab for refractory granulomatous eye disease. Clinical Ophthalmology, 6, 1613–1618. doi:10.2147/OPTH.S35521.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Mahevas, M., Lescure, F. X., Boffa, J. J., Delastour, V., Belenfant, X., Chapelon, C., et al. (2009). Renal sarcoidosis: Clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore), 88(2), 98–106.

    Article  Google Scholar 

  • Mallbris, L., Ljungberg, A., Hedblad, M. A., Larsson, P., & Stahle-Backdahl, M. (2003). Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy. Journal of the American Academy of Dermatology, 48(2), 290–293.

    Article  PubMed  Google Scholar 

  • Mana, J., & Marcoval, J. (2007). Erythema nodosum. Clinics in Dermatology, 25(3), 288–294.

    Article  PubMed  Google Scholar 

  • Marcellis, R. G., Lenssen, A. F., de Vries, G. J., Baughman, R. P., van der Grinten, C. P., Verschakelen, J. A., et al. (2013). Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients? Lung, 191, 43–52.

    Google Scholar 

  • Mason, R. S., Frankel, T., Chan, Y. L., Lissner, D., & Solomon, P. (1984). Vitamin D conversion by sarcoid lymph node homogenate. Annals of Internal Medicine, 100, 59–61.

    Article  CAS  PubMed  Google Scholar 

  • Mehta, D., Lubitz, S. A., Frankel, Z., Wisnivesky, J. P., Einstein, A. J., Goldman, M., et al. (2008). Cardiac involvement in patients with sarcoidosis: Diagnostic and prognostic value of outpatient testing. Chest, 133(6), 1426–1435.

    Article  PubMed  Google Scholar 

  • Moller, D. R., & Chen, E. S. (2002). Genetic basis of remitting sarcoidosis: Triumph of the trimolecular complex? American Journal of Respiratory Cell and Molecular Biology, 27(4), 391–395.

    Article  CAS  PubMed  Google Scholar 

  • Moravan, M., & Segal, B. M. (2009). Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil. Neurology, 72(4), 337–340.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Myers, T. D., Smith, J. R., Wertheim, M. S., Egan, R. A., Shults, W. T., & Rosenbaum, J. T. (2004). Use of corticosteroid sparing systemic immunosuppression for treatment of corticosteroid dependent optic neuritis not associated with demyelinating disease. British Journal of Ophthalmology, 88(5), 673–680.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nardi, A., Brillet, P. Y., Letoumelin, P., Girard, F., Brauner, M., Uzunhan, Y., et al. (2011). Stage IV sarcoidosis: comparison of survival with the general population and causes of death. European Respiratory Journal, 38(6), 1368–1373.

    Article  CAS  PubMed  Google Scholar 

  • Neville, E., Walker, A. N., & James, D. G. (1983). Prognostic factors predicting the outcome of sarcoidosis: An analysis of 818 patients. Quarterly Journal of Medicine, 208, 525–533.

    Google Scholar 

  • Ohira, H., Tsujino, I., Sato, T., Yoshinaga, K., Manabe, O., Oyama, N., et al. (2011). Early detection of cardiac sarcoid lesions with (18)F-fluoro-2-deoxyglucose positron emission tomography. Internal Medicine, 50(11), 1207–1209.

    Article  PubMed  Google Scholar 

  • Oswald-Richter, K. A., & Drake, W. P. (2010). The etiologic role of infectious antigens in sarcoidosis pathogenesis. Seminars in Respiratory and Critical Care Medicine, 31(4), 375–379.

    Article  PubMed  Google Scholar 

  • Paramothayan, S., Lasserson, T., & Walters, E. H. (2003). Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis. Cochrane Database of Systematic Reviews, 3, CD003536.

    Google Scholar 

  • Paramothayan, N. S., Lasserson, T. J., & Jones, P. W. (2005). Corticosteroids for pulmonary sarcoidosis. Cochrane Database of Systematic Reviews, 2, CD001114.

    Google Scholar 

  • Park, M. K., Fontana, J. R., Babaali, H., Gilbert-McClain, L. I., Joo, J., Moss, J., et al. (2009). Steroid sparing effects of pentoxifylline in pulmonary sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 26, 121–131.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Pawate, S., Moses, H., & Sriram, S. (2009). Presentations and outcomes of neurosarcoidosis: A study of 54 cases. QJM, 102, 449–460.

    Article  CAS  PubMed  Google Scholar 

  • Pietinalho, A., Tukiainen, P., Haahtela, T., Persson, T., Selroos, O., & Finnish Pulmonary Sarcoidosis Study Group. (1999). Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: A double-blind, placebo-controlled, multicenter study. Chest, 116, 424–431.

    Article  CAS  PubMed  Google Scholar 

  • Prieto, J. F., Dios, E., Gutierrez, J. M., Mayo, A., Calonge, M., & Herreras, J. M. (2001). Pars planitis: Epidemiology, treatment, and association with multiple sclerosis. Ocular Immunology and Inflammation, 9(2), 93–102.

    Article  CAS  PubMed  Google Scholar 

  • Rizzato, G., Fraioli, P., & Montemurro, L. (1995). Nephrolithiasis as a presenting feature of chronic sarcoidosis. Thorax, 50(5), 555–559.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rizzato, G., Montemurro, L., & Colombo, P. (1998). The late follow-up of chronic sarcoid patients previously treated with corticosteroids. Sarcoidosis, 15, 52–58.

    CAS  Google Scholar 

  • Rossman, M. D., Newman, L. S., Baughman, R. P., Teirstein, A., Weinberger, S. E., Miller, W. J., et al. (2006). A double-blind, randomized, placebo-controlled trial of infliximab in patients with active pulmonary sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 23, 201–208.

    PubMed  Google Scholar 

  • Salazar, A., Mana, J., Corbella, X., Albareda, J. M., & Pujol, R. (1995). Splenomegaly in sarcoidosis: A report of 16 cases. Sarcoidosis, 12, 131–134.

    CAS  PubMed  Google Scholar 

  • Samson, C. M., Waheed, N., Baltatzis, S., & Foster, C. S. (2001). Methotrexate therapy for chronic nonifectious uveitis: Analysis of a case series of 160 patients. Ophthalmology, 108, 1134–1139.

    Article  CAS  PubMed  Google Scholar 

  • Sato, H., Grutters, J. C., Pantelidis, P., Mizzon, A. N., Ahmad, T., Van Houte, A. J., et al. (2002). HLA-DQB1*0201: A marker for good prognosis in British and Dutch patients with sarcoidosis. American Journal of Respiratory Cell and Molecular Biology, 27(4), 406–412.

    Article  CAS  PubMed  Google Scholar 

  • Scadding, J. G. (1961). Prognosis of intrathoracic sarcoidosis in England. British Medical Journal, 4, 1165–1172.

    Article  Google Scholar 

  • Schuller, J. L., Zipse, M., Crawford, T., Bogun, F., Beshai, J., Patel, A. R., et al. (2012). Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. Journal of Cardiovascular Electrophysiology, 23(9), 925–929.

    Article  PubMed  Google Scholar 

  • Scott, T. F., Yandora, K., Valeri, A., Chieffe, C., & Schramke, C. (2007). Aggressive therapy for neurosarcoidosis: Long-term follow-up of 48 treated patients. Archives of Neurology, 64(5), 691–696.

    Article  PubMed  Google Scholar 

  • Scott, T. F., Yandora, K., Kunschner, L. J., & Schramke, C. (2010). Neurosarcoidosis mimicry of multiple sclerosis: Clinical, laboratory, and imaging characteristics. The Neurologist, 16(6), 386–389.

    Article  PubMed  Google Scholar 

  • Sekhri, V., Sanal, S., Delorenzo, L. J., Aronow, W. S., & Maguire, G. P. (2011). Cardiac sarcoidosis: A comprehensive review. Archives of Medical Science, 7(4), 546–554.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sharma, O. P. (2000). Hypercalcemia in granulomatous disorders: A clinical review. Current Opinion in Pulmonary Medicine, 6(5), 442–447.

    Article  CAS  PubMed  Google Scholar 

  • Shorr, A. F., Davies, D. B., & Nathan, S. D. (2003). Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest, 124(3), 922–928.

    Article  PubMed  Google Scholar 

  • Shorr, A. F., Helman, D. L., Davies, D. B., & Nathan, S. D. (2005). Pulmonary hypertension in advanced sarcoidosis: Epidemiology and clinical characteristics. European Respiratory Journal, 25(5), 783–788.

    Article  CAS  PubMed  Google Scholar 

  • Sodhi, M., Pearson, K., White, E. S., & Culver, D. A. (2009). Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis. Respiratory Medicine, 103(2), 268–273.

    Article  PubMed  Google Scholar 

  • Song, Z., Marzilli, L., Greenlee, B. M., Chen, E. S., Silver, R. F., Askin, F. B., et al. (2005). Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. Journal of Experimental Medicine, 201(5), 755–767.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Spencer, T. S., Campellone, J. V., Maldonado, I., Huang, N., Usmani, Q., & Reginato, A. J. (2005). Clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Seminars in Arthritis and Rheumatism, 34(4), 649–661.

    Article  PubMed  Google Scholar 

  • Stagaki, E., Mountford, W. K., Lackland, D. T., & Judson, M. A. (2009). The treatment of lupus pernio: Results of 116 treatment courses in 54 patients. Chest, 135(2), 468–476.

    Article  PubMed  Google Scholar 

  • Steckman, D. A., Schneider, P. M., Schuller, J. L., Aleong, R. G., Nguyen, D. T., Sinagra, G., et al. (2012). Utility of cardiac magnetic resonance imaging to differentiate cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy. American Journal of Cardiology, 110(4), 575–579.

    Article  PubMed  Google Scholar 

  • Swigris, J. J., Olson, A. L., Huie, T. J., Fernandez-Perez, E. R., Solomon, J., Sprunger, D., et al. (2011). Sarcoidosis-related mortality in the United States from 1988 to 2007. American Journal of Respiratory and Critical Care Medicine, 183(11), 1524–1530.

    Article  PubMed  PubMed Central  Google Scholar 

  • Tavee, J., & Zhou, L. (2009). Small fiber neuropathy: A burning problem. Cleveland Clinic Journal of Medicine, 76(5), 297–305.

    Article  PubMed  Google Scholar 

  • Uemura, A., Morimoto, S., Hiramitsu, S., Kato, Y., Ito, T., & Hishida, H. (1999). Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsies. American Heart Journal, 138(2 Pt 1), 299–302.

    Article  CAS  PubMed  Google Scholar 

  • Uthman, I., Touma, Z., & Khoury, M. (2007). Cardiac sarcoidosis responding to monotherapy with infliximab. Clinical Rheumatology, 26(11), 2001–2003.

    Article  PubMed  Google Scholar 

  • Warshauer, D. M., Molina, P. L., Hamman, S. M., Koehler, R. E., Paulson, E. K., Bechtold, R. E., et al. (1995). Nodular sarcoidosis of the liver and spleen: Analysis of 32 cases. Radiology, 195(3), 757–762.

    Article  CAS  PubMed  Google Scholar 

  • Yazaki, Y., Isobe, M., Hiroe, M., Morimoto, S., Hiramitsu, S., Nakano, T., et al. (2001). Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. American Journal of Cardiology, 88, 1006–1010.

    Article  CAS  PubMed  Google Scholar 

  • Yeager, H., Rossman, M. D., Baughman, R. P., Teirstein, A. S., Judson, M. A., Rabin, D. L., et al. (2005). Pulmonary and psychosocial findings at enrollment in the ACCESS study. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 22(2), 147–153.

    PubMed  Google Scholar 

  • Zajicek, J. P., Scolding, N. J., Foster, O., Rovaris, M., Evanson, J., Moseley, I. F., et al. (1999). Central nervous system sarcoidosis – Diagnosis and management. QJM, 92(Feb), 103–117.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Interstitial Lung Disease and Sarcoidosis Clinic, University of Cincinnati Medical Center, Holmes Eden Ave, Cincinnati, OH, 45267, USA

    Robert P. Baughman

Authors
  1. Robert P. Baughman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert P. Baughman .

Editor information

Editors and Affiliations

  1. Fraunhofer IME-TMP & JW Goethe University Frankfurt, Frankfurt am Main, Germany

    Michael J. Parnham

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing AG

About this entry

Cite this entry

Baughman, R.P. (2016). Sarcoidosis. In: Parnham, M.J. (eds) Compendium of Inflammatory Diseases. Springer, Basel. https://doi.org/10.1007/978-3-7643-8550-7_72

Download citation

Publish with us

Policies and ethics

Search

Navigation